öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÊ¯ÀÚ
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º32

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£º»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º 1£©miR-223ά³ÖÄÚƤÎÈ̬¶Ô¶¯ÂöÖàÑùÓ²»¯ÐγɵÄÓ°Ïì¼°»úÖÆÑо¿£»2£©ÐÂÐ͹Ǽܵ°°×¶ÔѪ¹ÜÐÂ... [Õ¹¿ª]


Ñо¿ÁìÓò£º 1£©miR-223ά³ÖÄÚƤÎÈ̬¶Ô¶¯ÂöÖàÑùÓ²»¯ÐγɵÄÓ°Ïì¼°»úÖÆÑо¿£»2£©ÐÂÐ͹Ǽܵ°°×¶ÔѪ¹ÜÐÂÉú¼°Ñª¹ÜÎÈ̬µ÷½Ú¼°»úÖÆÑо¿£»3£©»ùÓڷDZàÂëRNAµÄ±í´ïµ÷¿ØÑо¿¼°Ó¦Óà [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºpowerleishi@126.com


¸öÈ˼òÊö :
ʯÀÚ£¬²©Ê¿£¬¸±½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦¡£ÏÖÈδóÁ¬Ò½¿Æ´óѧ»ù´¡Ò½Ñ§Ôº, ¡°³¤½­Ñ§ÕßʵÑéÊÒ¡±½Ìʦ¡£2014ÄêÈëÑ¡¡°ÁÉÄþÊ¡°ÙǧÍòÈ˲Ź¤³ÌÍò²ã´ÎÈ˲š±£»2015ÄêÈëÑ¡´óÁ¬ÊС°¿Æ¼¼Ö®ÐÇ¡±¼Æ»®£»µ£Èιú¼Ò×ÔÈ»»ù½ðί³õÉóר¼Ò£¬ Oncotarget, Tumor biologyµÈ¹ú¼ÊѧÊõÆÚ¿¯Éó¸åÈË¡£2014ÄêÖÁ½ñ£¬Ö÷³Ö¹ú×ÔÈ»ÃæÉÏÏîÄ¿Ò»ÏÖ÷³Ö¹ú×ÔÈ»ÇàÄêÏîÄ¿Ò»Ï½ÌÓý²¿Áôѧ»Ø¹úÈËÔ±Æô¶¯ÏîÄ¿Ò»ÏÁÉÄþÊ¡²©Ê¿Æô¶¯ÏîÄ¿Ò»ÏÖпÆÔºÒ©ÎïÑо¿Ëù¹ú¼ÒÖصãʵÑéÊÒ¿ª·Å¿ÎÌâÒ»Ïî¡£ÒÔµÚÒ»×÷ÕߺͲÎÓë×÷Õß·¢±íSCIÂÛÎÄ11ƪ£¬ÆäÖÐͨѶ»òµÚÒ»×÷ÕßÂÛÎÄ8ƪ, °üÀ¨ÔÚÐÄѪ¹ÜÁìÓò¾ßÓнϸßÓ°ÏìÁ¦µÄöλÔÓéÀֵǼÈë¿ÚÏÂÔØÔÓÖ¾£¬Circulation Research, Hypertension£¬ Cardiovascular researchµÈ¡£

¿ÆÑй¤×÷ :
³Ðµ£µÄ¹ú¼Ò¼¶ÏîÄ¿£º£¨½ü5Ä꣩
1¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬**¡¢MiRNA-223µ÷¿ØѪ¹ÜÄÚƤ»î»¯ÔÚ¶¯ÂöÖàÑùÓ²»¯·¢ÉúÖеÄ×÷Óü°»úÖÆÑо¿¡¢2016/01-2019/12¡¢ 68.4ÍòÔª¡¢ÔÚÑС¢Ö÷³Ö¡£
2¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄêÏîÄ¿£¬**¡¢Septin2ͨ¹ýµ÷¿ØÄÚƤϸ°ûITGB1µÄ±í´ïÓ°ÏìÖ×ÁöѪ¹ÜÐÂÉúµÄ»úÖÆÑо¿¡¢2015/01-2017/12¡¢24ÍòÔª¡¢ÔÚÑС¢Ö÷³Ö¡£
´ú±íÐÔÂÛÎÄ£¨½ü5Ä꣩£º
1¡¢ Zhang N, Liu L, Fan N, Zhang Q, Wang W, Zheng M, Ma L, Li Y, Shi L, The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation. Oncotarget. 2016 Aug 19. doi: 10.18632/oncotarget.11402. (Lei Shi, ͨѶ×÷ÕßIF 5.008)
2¡¢ Lei Shi, Baktybek Kojonazarov, Amro Elgheznawy, R¨¹diger Popp, Bhola Kumar Dahal, Mario B?hm, Soni Savai Pullamsetti, Hossein-Ardeschir Ghofrani, Axel G?decke, Andreas Jungmann, Hugo A. Katus, Oliver J. M¨¹ller, Ralph T. Schermuly, Beate Fisslthaler, Werner Seeger, Ingrid Fleming, miR-223¨CIGF-IR signaling in hypoxia- and load-induced right ventricular failure: a novel 2 therapeutic approach£¬Cardiovasc Res. 2016 Aug 1111(3):184-93. doi: 10.1093/cvr/cvw065 (IF:5.94)
3¡¢ Ning Tang+, Lei Shi+, Zhenlong Yu+, Peipei Dong, Chao Wang, Xiaokui Huo, Baojing Zhang, Shanshan Huang, Sa Deng, Kexin Liu, Tonghui Ma , Xiaobo Wang, Lijun Wu, Xiaochi Ma. Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway, Oncotarget. 2016 Jan 197(3):3533-47. doi: 10.18632/oncotarget.6514 (IF 5.008, +²¢ÁÐÒ»×÷)
4¡¢ Elgheznawy A, Shi Lei, Randriamboavonjy V and Fleming I. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes, Circ Res 2015.05.05 ( IF 11.86)
5¡¢ Khader Awwad, Jiong Hu, Lei Shi, Nicole Lill, Randa Abdel Malik, Nina Zippel, Beate Fisslthaler, Johannes A. Eble, Josef Pfeilschifter, R¨¹diger Popp, Ingrid Fleming. Role of secreted modular calcium binding protein 1 (SMOC1) in transforming growth factor ¦Â signaling and angiogenesis, Cardiovascular research. 2015 May 1106(2):284-94. doi: 10.1093/cvr/cvv098. Epub 2015 Mar 5. (IF:5.808)
6¡¢ Shi L, Fisslthaler B, Zippel N, Fr?mel T, Hu J, Elgheznawy A, Heide H, Popp R, Fleming I. MicroRNA-223 Antagonizes Angiogenesis by Targeting ¦Â1 Integrin and Preventing Growth Factor Signaling in Endothelial Cells. Circ Res 113(12):1320-30. 2013 Dec 6 £¨IF: 11.861£©
7¡¢ Kohlstedt K, Trouvain C, Boettger T, Shi L, Fisslthaler B, Fleming I.AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143/145. Circ Res 112(8):1150-8. 2013 Apr 12 £¨IF: 11.861£©
8¡¢ Shi L, Fleming I.One miR level of control: microRNA-155 directly regulates endothelial nitric oxide synthase mRNA and protein levels. Hypertension 60(6):1381-2. 2012 Dec £¨IF: 6.873£©

½ÌÓý±³¾° :
2008Äê9Ô¡ª¡ª2012Äê4Ô ÉúÎïѧ²©Ê¿ µÂ¹ú·¨À¼¿Ë¸£´óѧ£»2004Äê9Ô¡ª¡ª2007Äê7Ô ҩÀíѧ˶ʿ Öйú¿ÆѧԺÉϺ£Ò©ÎïÑо¿Ëù£»2000Äê9Ô¡ª¡ª2004Äê7Ô ÉúÎï¼¼Êõѧʿ ÄÚÃɹŴóѧ¡£